Firefly BioWorks is introducing an open platform that will allow industrial, academic, and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. Their mission is to develop reliable and affordable solutions for the comprehensive monitoring of biological function.
For the story of the Deshpande Center project that became Firefly BioWorks, see Case Studies.
This company is a spinout of the 2007 project, Rapid Mutiplexed Analysis for Molecular Diagnostics.
Watch the CTO and co-founder, Daniel Pregibon, present the Firefly BioWorks story at IdeaStream 2014 below.
In the News:
In January 2015, Firefly BioWorks was acquired by Abcam.